STOCK TITAN

[Form 4] ZOETIS INC. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Form 4 filed with the SEC reports Zoetis Inc. (ZTS) Chief Financial Officer Joseph Wetteny acquired additional deferred-compensation units on 07/11/2025.

  • Derivative security: 181.4947 phantom stock units credited to the executive’s Zoetis Supplemental Savings Plan account (Code “A” – acquisition).
  • Economic exposure: Each unit tracks the value of Zoetis common stock plus a small cash-equivalent component; reference price stated as $50.86.
  • Sizing: The transaction represents the economic equivalent of 59.5691 Zoetis shares (per table) and raises the executive’s total phantom-unit balance to 6,355.4377.
  • Settlement: Units are settled in cash after the executive separates from service and can be reallocated among plan investment options, subject to company restrictions (Footnote 1).

The filing records routine deferred-compensation activity; no common shares were issued, and the transaction does not affect Zoetis’s share count or cash flow.

Il modulo 4 depositato presso la SEC riporta che Joseph Wetteny, Chief Financial Officer di Zoetis Inc. (ZTS), ha acquisito ulteriori unità di compensazione differita il 11/07/2025.

  • Strumento derivato: 181,4947 unità di azioni fantasma accreditate sul conto del piano di risparmio supplementare Zoetis dell’esecutivo (Codice “A” – acquisizione).
  • Esposizione economica: Ogni unità riflette il valore delle azioni ordinarie Zoetis più una piccola componente equivalente in contanti; prezzo di riferimento indicato a 50,86 $.
  • Dimensione: La transazione rappresenta l’equivalente economico di 59,5691 azioni Zoetis (secondo la tabella) e porta il saldo totale delle unità fantasma dell’esecutivo a 6.355,4377.
  • Regolamento: Le unità vengono liquidate in contanti dopo la cessazione del rapporto di lavoro e possono essere riallocate tra le opzioni di investimento del piano, soggette a restrizioni aziendali (Nota 1).

Il deposito registra un’attività ordinaria di compensazione differita; non sono state emesse azioni ordinarie e la transazione non influisce sul numero di azioni Zoetis né sui flussi di cassa.

El formulario 4 presentado ante la SEC informa que Joseph Wetteny, Director Financiero de Zoetis Inc. (ZTS), adquirió unidades adicionales de compensación diferida el 11/07/2025.

  • Valor derivado: 181,4947 unidades de acciones fantasma acreditadas en la cuenta del Plan Suplementario de Ahorros de Zoetis del ejecutivo (Código “A” – adquisición).
  • Exposición económica: Cada unidad refleja el valor de las acciones ordinarias de Zoetis más un pequeño componente equivalente en efectivo; precio de referencia declarado en 50,86 $.
  • Tamaño: La transacción representa el equivalente económico de 59,5691 acciones de Zoetis (según tabla) y eleva el saldo total de unidades fantasma del ejecutivo a 6.355,4377.
  • Liquidación: Las unidades se liquidan en efectivo tras la separación del ejecutivo del servicio y pueden reasignarse entre las opciones de inversión del plan, sujetas a restricciones de la empresa (Nota 1).

La presentación registra una actividad rutinaria de compensación diferida; no se emitieron acciones ordinarias y la transacción no afecta el conteo de acciones ni el flujo de efectivo de Zoetis.

SEC에 제출된 Form 4에 따르면 Zoetis Inc. (ZTS) 최고재무책임자 Joseph Wetteny가 2025년 7월 11일 추가 연기 보상 단위를 취득했습니다.

  • 파생 증권: 경영진의 Zoetis 보충 저축 계획 계좌에 181.4947개의 팬텀 스톡 유닛이 적립됨(코드 “A” – 취득).
  • 경제적 노출: 각 단위는 Zoetis 보통주의 가치와 소액의 현금 등가물을 추적하며; 기준 가격은 $50.86로 명시됨.
  • 규모: 이 거래는 경제적으로 59.5691 Zoetis 주식과 동일하며(표 참조), 경영진의 총 팬텀 유닛 잔액을 6,355.4377로 증가시킴.
  • 정산: 단위는 경영진이 퇴직한 후 현금으로 정산되며, 회사 제한 사항(각주 1)에 따라 플랜 투자 옵션 간 재배분이 가능함.

이 제출 서류는 일상적인 연기 보상 활동을 기록하며; 보통주는 발행되지 않았고, 이 거래는 Zoetis의 주식 수나 현금 흐름에 영향을 미치지 않습니다.

Le formulaire 4 déposé auprès de la SEC rapporte que Joseph Wetteny, Directeur Financier de Zoetis Inc. (ZTS), a acquis des unités supplémentaires de compensation différée le 11/07/2025.

  • Valeur dérivée : 181,4947 unités d’actions fantômes créditées sur le compte du Plan d’Épargne Supplémentaire de Zoetis de l’exécutif (Code « A » – acquisition).
  • Exposition économique : Chaque unité suit la valeur des actions ordinaires de Zoetis plus une petite composante équivalente en espèces ; prix de référence indiqué à 50,86 $.
  • Dimension : La transaction représente l’équivalent économique de 59,5691 actions Zoetis (selon tableau) et porte le solde total des unités fantômes de l’exécutif à 6 355,4377.
  • Règlement : Les unités sont réglées en espèces après la séparation de l’exécutif et peuvent être réaffectées parmi les options d’investissement du plan, sous réserve des restrictions de l’entreprise (Note 1).

Le dépôt enregistre une activité courante de compensation différée ; aucune action ordinaire n’a été émise et la transaction n’affecte ni le nombre d’actions de Zoetis ni les flux de trésorerie.

Das bei der SEC eingereichte Formular 4 meldet, dass Joseph Wetteny, Chief Financial Officer von Zoetis Inc. (ZTS), am 11.07.2025 zusätzliche aufgeschobene Vergütungseinheiten erworben hat.

  • Derivative Sicherheit: 181,4947 Phantom-Aktieneinheiten, die dem Konto des Zoetis Supplemental Savings Plan des Geschäftsführers gutgeschrieben wurden (Code „A“ – Erwerb).
  • Wirtschaftliche Exponierung: Jede Einheit bildet den Wert der Zoetis-Stammaktien plus eine kleine barwertige Komponente ab; Referenzpreis angegeben mit 50,86 $.
  • Größe: Die Transaktion entspricht wirtschaftlich 59,5691 Zoetis-Aktien (laut Tabelle) und erhöht den Gesamtbestand der Phantom-Einheiten des Geschäftsführers auf 6.355,4377.
  • Abwicklung: Die Einheiten werden in bar nach Ausscheiden des Geschäftsführers aus dem Unternehmen abgerechnet und können unternehmensbedingten Beschränkungen (Fußnote 1) zufolge innerhalb der Anlagemöglichkeiten des Plans umgeschichtet werden.

Die Meldung dokumentiert eine routinemäßige Tätigkeit im Bereich der aufgeschobenen Vergütung; es wurden keine Stammaktien ausgegeben, und die Transaktion hat keine Auswirkungen auf die Aktienanzahl oder den Cashflow von Zoetis.

Positive
  • None.
Negative
  • None.

Insights

TL;DR — Routine deferred-comp plan credit; immaterial to ZTS equity, neutral signal.

The CFO’s purchase of 181 phantom stock units (<≈ $9 k) through the Supplemental Savings Plan simply increases his cash-settled exposure to Zoetis stock. Because phantom units do not convert into shares and are paid out in cash upon separation, the event is non-dilutive and has no balance-sheet impact. Insider alignment marginally improves, but the dollar value is too small to draw meaningful conclusions about future performance or insider sentiment. From a valuation or liquidity standpoint, the disclosure is not impactful.

Il modulo 4 depositato presso la SEC riporta che Joseph Wetteny, Chief Financial Officer di Zoetis Inc. (ZTS), ha acquisito ulteriori unità di compensazione differita il 11/07/2025.

  • Strumento derivato: 181,4947 unità di azioni fantasma accreditate sul conto del piano di risparmio supplementare Zoetis dell’esecutivo (Codice “A” – acquisizione).
  • Esposizione economica: Ogni unità riflette il valore delle azioni ordinarie Zoetis più una piccola componente equivalente in contanti; prezzo di riferimento indicato a 50,86 $.
  • Dimensione: La transazione rappresenta l’equivalente economico di 59,5691 azioni Zoetis (secondo la tabella) e porta il saldo totale delle unità fantasma dell’esecutivo a 6.355,4377.
  • Regolamento: Le unità vengono liquidate in contanti dopo la cessazione del rapporto di lavoro e possono essere riallocate tra le opzioni di investimento del piano, soggette a restrizioni aziendali (Nota 1).

Il deposito registra un’attività ordinaria di compensazione differita; non sono state emesse azioni ordinarie e la transazione non influisce sul numero di azioni Zoetis né sui flussi di cassa.

El formulario 4 presentado ante la SEC informa que Joseph Wetteny, Director Financiero de Zoetis Inc. (ZTS), adquirió unidades adicionales de compensación diferida el 11/07/2025.

  • Valor derivado: 181,4947 unidades de acciones fantasma acreditadas en la cuenta del Plan Suplementario de Ahorros de Zoetis del ejecutivo (Código “A” – adquisición).
  • Exposición económica: Cada unidad refleja el valor de las acciones ordinarias de Zoetis más un pequeño componente equivalente en efectivo; precio de referencia declarado en 50,86 $.
  • Tamaño: La transacción representa el equivalente económico de 59,5691 acciones de Zoetis (según tabla) y eleva el saldo total de unidades fantasma del ejecutivo a 6.355,4377.
  • Liquidación: Las unidades se liquidan en efectivo tras la separación del ejecutivo del servicio y pueden reasignarse entre las opciones de inversión del plan, sujetas a restricciones de la empresa (Nota 1).

La presentación registra una actividad rutinaria de compensación diferida; no se emitieron acciones ordinarias y la transacción no afecta el conteo de acciones ni el flujo de efectivo de Zoetis.

SEC에 제출된 Form 4에 따르면 Zoetis Inc. (ZTS) 최고재무책임자 Joseph Wetteny가 2025년 7월 11일 추가 연기 보상 단위를 취득했습니다.

  • 파생 증권: 경영진의 Zoetis 보충 저축 계획 계좌에 181.4947개의 팬텀 스톡 유닛이 적립됨(코드 “A” – 취득).
  • 경제적 노출: 각 단위는 Zoetis 보통주의 가치와 소액의 현금 등가물을 추적하며; 기준 가격은 $50.86로 명시됨.
  • 규모: 이 거래는 경제적으로 59.5691 Zoetis 주식과 동일하며(표 참조), 경영진의 총 팬텀 유닛 잔액을 6,355.4377로 증가시킴.
  • 정산: 단위는 경영진이 퇴직한 후 현금으로 정산되며, 회사 제한 사항(각주 1)에 따라 플랜 투자 옵션 간 재배분이 가능함.

이 제출 서류는 일상적인 연기 보상 활동을 기록하며; 보통주는 발행되지 않았고, 이 거래는 Zoetis의 주식 수나 현금 흐름에 영향을 미치지 않습니다.

Le formulaire 4 déposé auprès de la SEC rapporte que Joseph Wetteny, Directeur Financier de Zoetis Inc. (ZTS), a acquis des unités supplémentaires de compensation différée le 11/07/2025.

  • Valeur dérivée : 181,4947 unités d’actions fantômes créditées sur le compte du Plan d’Épargne Supplémentaire de Zoetis de l’exécutif (Code « A » – acquisition).
  • Exposition économique : Chaque unité suit la valeur des actions ordinaires de Zoetis plus une petite composante équivalente en espèces ; prix de référence indiqué à 50,86 $.
  • Dimension : La transaction représente l’équivalent économique de 59,5691 actions Zoetis (selon tableau) et porte le solde total des unités fantômes de l’exécutif à 6 355,4377.
  • Règlement : Les unités sont réglées en espèces après la séparation de l’exécutif et peuvent être réaffectées parmi les options d’investissement du plan, sous réserve des restrictions de l’entreprise (Note 1).

Le dépôt enregistre une activité courante de compensation différée ; aucune action ordinaire n’a été émise et la transaction n’affecte ni le nombre d’actions de Zoetis ni les flux de trésorerie.

Das bei der SEC eingereichte Formular 4 meldet, dass Joseph Wetteny, Chief Financial Officer von Zoetis Inc. (ZTS), am 11.07.2025 zusätzliche aufgeschobene Vergütungseinheiten erworben hat.

  • Derivative Sicherheit: 181,4947 Phantom-Aktieneinheiten, die dem Konto des Zoetis Supplemental Savings Plan des Geschäftsführers gutgeschrieben wurden (Code „A“ – Erwerb).
  • Wirtschaftliche Exponierung: Jede Einheit bildet den Wert der Zoetis-Stammaktien plus eine kleine barwertige Komponente ab; Referenzpreis angegeben mit 50,86 $.
  • Größe: Die Transaktion entspricht wirtschaftlich 59,5691 Zoetis-Aktien (laut Tabelle) und erhöht den Gesamtbestand der Phantom-Einheiten des Geschäftsführers auf 6.355,4377.
  • Abwicklung: Die Einheiten werden in bar nach Ausscheiden des Geschäftsführers aus dem Unternehmen abgerechnet und können unternehmensbedingten Beschränkungen (Fußnote 1) zufolge innerhalb der Anlagemöglichkeiten des Plans umgeschichtet werden.

Die Meldung dokumentiert eine routinemäßige Tätigkeit im Bereich der aufgeschobenen Vergütung; es wurden keine Stammaktien ausgegeben, und die Transaktion hat keine Auswirkungen auf die Aktienanzahl oder den Cashflow von Zoetis.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Driscoll Rimma

(Last) (First) (Middle)
C/O ZOETIS INC.
10 SYLVAN WAY

(Street)
PARSIPPANY NJ 07054

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Executive Vice President
3. Date of Earliest Transaction (Month/Day/Year)
07/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock Unit(1) (2) 07/11/2025 A 117.9709 (1) (1) Common Stock 38.7197 $50.86 5,076.5011 D
Explanation of Responses:
1. These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.
2. Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.
Remarks:
/s/ Brenda Santuccio, as Attorney-in-Fact 07/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Zoetis CFO Joseph Wetteny report in the latest Form 4?

He acquired 181.4947 phantom stock units on 07/11/2025 under the Zoetis Supplemental Savings Plan.

Do the phantom stock units increase Zoetis (ZTS) shares outstanding?

No. The units are cash-settled deferred-compensation instruments and do not create new shares.

What is the reference price for the newly credited phantom stock units?

The table lists a price of $50.86 per unit.

How many phantom stock units does the CFO now hold in total?

After the transaction, he beneficially owns 6,355.4377 units.

Why is insider acquisition of phantom stock considered neutral for investors?

Because the units are settled in cash and involve a small dollar amount, they do not affect equity supply or signal material strategic changes.
Zoetis Inc

NYSE:ZTS

ZTS Rankings

ZTS Latest News

ZTS Latest SEC Filings

ZTS Stock Data

70.25B
444.19M
0.21%
95.67%
1.45%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
PARSIPPANY